Remove Bottom-up Remove Compliance Remove Ethics Remove Pharmaceuticals
article thumbnail

Compliance Alone Won’t Make Your Company Safe

Harvard Business Review

Despite some early warnings, both the regulators and the company did not really follow up the case until it was too late. The dominant response to this state of affairs has been — and still is — to appoint an ever-increasing number of compliance officers. billion from a series of high-risk trades.